Hybio Pharmaceutical (300199) — Cash Flow-to-Debt Ratio
Hybio Pharmaceutical (300199) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.78 Million could theoretically repay 0% of its total liabilities (CN¥2.50 Billion) in one year. Explore Hybio Pharmaceutical (300199) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hybio Pharmaceutical Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Hybio Pharmaceutical across 18 annual periods. Also explore Hybio Pharmaceutical total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hybio Pharmaceutical (2007–2024)
Year-by-year debt coverage analysis for Hybio Pharmaceutical. For market capitalisation and broader financial context, see Hybio Pharmaceutical (300199) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥164.71 Million | CN¥2.41 Billion | ▲ +4917.1% |
| 2023 | 0.00x | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -120.8% |
| 2022 | 0.01x | CN¥15.81 Million | CN¥2.31 Billion | ▼ -90.2% |
| 2021 | 0.07x | CN¥156.83 Million | CN¥2.26 Billion | ▲ +238.9% |
| 2020 | 0.02x | CN¥47.99 Million | CN¥2.34 Billion | ▼ -51.2% |
| 2019 | 0.04x | CN¥104.64 Million | CN¥2.49 Billion | ▲ +102.7% |
| 2018 | 0.02x | CN¥47.00 Million | CN¥2.27 Billion | ▼ -86.3% |
| 2017 | 0.15x | CN¥213.74 Million | CN¥1.41 Billion | ▼ -56.5% |
| 2016 | 0.35x | CN¥296.41 Million | CN¥852.42 Million | ▲ +127.6% |
| 2015 | 0.15x | CN¥138.84 Million | CN¥908.68 Million | ▼ -60.0% |
| 2014 | 0.38x | CN¥153.43 Million | CN¥401.32 Million | ▼ -59.0% |
| 2013 | 0.93x | CN¥153.48 Million | CN¥164.48 Million | ▲ +15.0% |
| 2012 | 0.81x | CN¥87.19 Million | CN¥107.42 Million | ▼ -33.3% |
| 2011 | 1.22x | CN¥72.48 Million | CN¥59.56 Million | ▼ -28.1% |
| 2010 | 1.69x | CN¥54.69 Million | CN¥32.30 Million | ▲ +255.0% |
| 2009 | 0.48x | CN¥26.11 Million | CN¥54.73 Million | ▼ -61.1% |
| 2008 | 1.23x | CN¥45.75 Million | CN¥37.32 Million | ▼ -76.2% |
| 2007 | 5.14x | CN¥49.04 Million | CN¥9.54 Million | — |